Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Macrogenics Analyst Ratings and Price Targets | NASDAQ:MGNX | Benzinga
Macrogenics Inc has a consensus price target of $8.11 based on the ratings of 14 analysts. The high is $17 issued by Stifel on November 27, 2023. The low is $2 issued by HC Wainwright & Co. on March 25, 2025. The 3 most-recent analyst ratings were released by B. Riley Securities, Stifel, and Barclays on May 20, 2025, May 14, 2025, and May 14, 2025, respectively. With an average price target of $3.67 between B. Riley Securities, Stifel, and Barclays, there's an implied 163.79% upside for Macrogenics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
B. Riley Securities
Stifel
Barclays
HC Wainwright & Co.
Citigroup
1calculated from analyst ratings
Analyst Ratings for Macrogenics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/20/2025 | Buy Now | 115.83% | B. Riley Securities | Mayank Mamtani72% | $5 → $3 | Maintains | Neutral | Get Alert |
| 05/14/2025 | Buy Now | 259.71% | Stifel | Stephen Willey52% | $6 → $5 | Maintains | Hold | Get Alert |
| 05/14/2025 | Buy Now | 115.83% | Barclays | Peter Lawson43% | $8 → $3 | Maintains | Overweight | Get Alert |
| 03/25/2025 | Buy Now | 43.88% | HC Wainwright & Co. | Robert Burns46% | $4 → $2 | Maintains | Neutral | Get Alert |
| 11/07/2024 | Buy Now | — | JMP Securities | Silvan Tuerkcan47% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 11/06/2024 | Buy Now | 187.77% | HC Wainwright & Co. | Robert Burns46% | $4 → $4 | Reiterates | Neutral → Neutral | Get Alert |
| 09/18/2024 | Buy Now | 187.77% | HC Wainwright & Co. | Robert Burns46% | $4 → $4 | Reiterates | Neutral → Neutral | Get Alert |
| 08/21/2024 | Buy Now | 187.77% | HC Wainwright & Co. | Robert Burns46% | $4 → $4 | Reiterates | Neutral → Neutral | Get Alert |
| 08/15/2024 | Buy Now | 907.19% | Citigroup | Yigal Nochomovitz54% | $16 → $14 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | 259.71% | BMO Capital | Etzer Darout48% | $8 → $5 | Maintains | Market Perform | Get Alert |
| 08/01/2024 | Buy Now | — | BTIG | Kaveri Pohlman25% | — | Downgrade | Buy → Neutral | Get Alert |
| 08/01/2024 | Buy Now | 187.77% | HC Wainwright & Co. | Robert Burns46% | $4 → $4 | Reiterates | Neutral → Neutral | Get Alert |
| 07/31/2024 | Buy Now | 475.54% | JMP Securities | Silvan Tuerkcan47% | $16 → $8 | Maintains | Market Outperform | Get Alert |
| 07/31/2024 | Buy Now | 475.54% | Barclays | Peter Lawson43% | $9 → $8 | Maintains | Overweight | Get Alert |
| 07/31/2024 | Buy Now | — | Guggenheim | Kelsey Goodwin50% | — | Downgrade | Buy → Neutral | Get Alert |
| 07/31/2024 | Buy Now | 259.71% | B. Riley Securities | Mayank Mamtani72% | $18 → $5 | Downgrade | Buy → Neutral | Get Alert |
| 07/29/2024 | Buy Now | 547.48% | Barclays | Peter Lawson43% | $14 → $9 | Maintains | Overweight | Get Alert |
| 05/24/2024 | Buy Now | 547.48% | BTIG | Kaveri Pohlman25% | $24 → $9 | Maintains | Buy | Get Alert |
| 05/13/2024 | Buy Now | 187.77% | HC Wainwright & Co. | Robert Burns46% | $16 → $4 | Maintains | Neutral | Get Alert |
| 05/10/2024 | Buy Now | 907.19% | Barclays | Peter Lawson43% | $25 → $14 | Maintains | Overweight | Get Alert |
| 05/10/2024 | Buy Now | 1051.08% | JMP Securities | Silvan Tuerkcan47% | $22 → $16 | Maintains | Market Outperform | Get Alert |
| 05/10/2024 | Buy Now | 475.54% | BMO Capital | Etzer Darout48% | $24 → $8 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/10/2024 | Buy Now | — | TD Cowen | Boris Peaker49% | — | Downgrade | Buy → Hold | Get Alert |
| 05/10/2024 | Buy Now | 403.6% | Stifel | Stephen Willey52% | $29 → $7 | Downgrade | Buy → Hold | Get Alert |
| 04/09/2024 | Buy Now | — | TD Cowen | Boris Peaker49% | — | Upgrade | Hold → Buy | Get Alert |
| 04/04/2024 | Buy Now | — | JMP Securities | Silvan Tuerkcan47% | — | Reiterates | → Market Outperform | Get Alert |
| 03/11/2024 | Buy Now | 1698.56% | Citigroup | Yigal Nochomovitz54% | $13 → $25 | Maintains | Buy | Get Alert |
| 03/11/2024 | Buy Now | 1482.73% | JMP Securities | Silvan Tuerkcan47% | $16 → $22 | Maintains | Outperform | Get Alert |
| 03/11/2024 | Buy Now | 1051.08% | HC Wainwright & Co. | Robert Burns46% | $14 → $16 | Maintains | Neutral | Get Alert |
| 03/08/2024 | Buy Now | 1626.62% | BMO Capital | Etzer Darout48% | $18 → $24 | Maintains | Outperform | Get Alert |
| 03/08/2024 | Buy Now | 1986.33% | Stifel | Stephen Willey52% | $17 → $29 | Maintains | Buy | Get Alert |
| 03/08/2024 | Buy Now | 1698.56% | Barclays | Peter Lawson43% | $23 → $25 | Maintains | Overweight | Get Alert |
| 03/04/2024 | Buy Now | 1626.62% | BTIG | Kaveri Pohlman25% | $12 → $24 | Maintains | Buy | Get Alert |
| 02/29/2024 | Buy Now | 1554.68% | Barclays | Peter Lawson43% | $12 → $23 | Maintains | Overweight | Get Alert |
| 02/14/2024 | Buy Now | 907.19% | HC Wainwright & Co. | Robert Burns46% | $12 → $14 | Downgrade | Buy → Neutral | Get Alert |
| 01/24/2024 | Buy Now | 1051.08% | JMP Securities | Silvan Tuerkcan47% | $10 → $16 | Maintains | Market Outperform | Get Alert |
| 12/20/2023 | Buy Now | 835.25% | Citigroup | Yigal Nochomovitz54% | $7 → $13 | Upgrade | Neutral → Buy | Get Alert |
| 11/27/2023 | Buy Now | 1123.02% | Stifel | Jonathan Block72% | → $17 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2023 | Buy Now | 763.31% | HC Wainwright & Co. | Robert Burns46% | $14 → $12 | Maintains | Buy | Get Alert |
| 11/07/2023 | Buy Now | 763.31% | Guggenheim | Charles Zhu64% | → $12 | Upgrade | Neutral → Buy | Get Alert |
| 08/10/2023 | Buy Now | 907.19% | HC Wainwright & Co. | Robert Burns46% | → $14 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | Buy Now | 619.42% | JMP Securities | Silvan Tuerkcan47% | $8 → $10 | Maintains | Market Outperform | Get Alert |
| 04/03/2023 | Buy Now | 907.19% | HC Wainwright & Co. | Robert Burns46% | → $14 | Reiterates | → Buy | Get Alert |
| 03/21/2023 | Buy Now | 763.31% | BTIG | Kaveri Pohlman25% | $6 → $12 | Maintains | Buy | Get Alert |
| 03/20/2023 | Buy Now | 907.19% | HC Wainwright & Co. | Robert Burns46% | $12 → $14 | Maintains | Buy | Get Alert |
| 03/17/2023 | Buy Now | — | Guggenheim | Charles Zhu64% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/16/2023 | Buy Now | 475.54% | JMP Securities | Silvan Tuerkcan47% | → $8 | Reiterates | → Market Outperform | Get Alert |
| 01/19/2023 | Buy Now | 475.54% | JMP Securities | Silvan Tuerkcan47% | $18 → $8 | Maintains | Market Outperform | Get Alert |
| 11/23/2022 | Buy Now | 403.6% | Citigroup | Yigal Nochomovitz54% | $16 → $7 | Downgrade | Buy → Neutral | Get Alert |
| 11/23/2022 | Buy Now | 763.31% | Guggenheim | Charles Zhu64% | → $12 | Upgrade | Neutral → Buy | Get Alert |
| 11/22/2022 | Buy Now | — | Cowen & Co. | Boris Peaker49% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/14/2022 | Buy Now | 1051.08% | BMO Capital | Etzer Darout48% | $5.7 → $16 | Upgrade | Market Perform → Outperform | Get Alert |
| 11/07/2022 | Buy Now | 763.31% | HC Wainwright & Co. | Robert Burns46% | $11 → $12 | Maintains | Buy | Get Alert |
| 10/18/2022 | Buy Now | 691.37% | HC Wainwright & Co. | Robert Burns46% | $10 → $11 | Maintains | Buy | Get Alert |
| 09/12/2022 | Buy Now | 619.42% | HC Wainwright & Co. | Robert Burns46% | $35 → $10 | Maintains | Buy | Get Alert |
| 08/29/2022 | Buy Now | 1051.08% | Citigroup | Yigal Nochomovitz54% | $13 → $16 | Maintains | Buy | Get Alert |
| 08/09/2022 | Buy Now | 763.31% | SVB Leerink | Jonathan Chang38% | $15 → $12 | Maintains | Outperform | Get Alert |
| 08/09/2022 | Buy Now | 475.54% | Barclays | Peter Lawson43% | $18 → $8 | Maintains | Overweight | Get Alert |
| 07/12/2022 | Buy Now | 1338.85% | JMP Securities | Silvan Tuerkcan47% | $24 → $20 | Maintains | Market Outperform | Get Alert |
| 07/12/2022 | Buy Now | 187.77% | BMO Capital | Etzer Darout48% | $31 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
| 07/11/2022 | Buy Now | 187.77% | BMO Capital | Etzer Darout48% | $31 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
FAQ
What is the target price for Macrogenics (MGNX) stock?
The latest price target for Macrogenics (NASDAQ:MGNX) was reported by B. Riley Securities on May 20, 2025. The analyst firm set a price target for $3.00 expecting MGNX to rise to within 12 months (a possible 115.83% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Macrogenics (MGNX)?
The latest analyst rating for Macrogenics (NASDAQ:MGNX) was provided by B. Riley Securities, and Macrogenics maintained their neutral rating.
When was the last upgrade for Macrogenics (MGNX)?
The last upgrade for Macrogenics Inc happened on April 9, 2024 when TD Cowen raised their price target to N/A. TD Cowen previously had a hold for Macrogenics Inc.
When was the last downgrade for Macrogenics (MGNX)?
The last downgrade for Macrogenics Inc happened on November 7, 2024 when JMP Securities changed their price target from N/A to N/A for Macrogenics Inc.
When is the next analyst rating going to be posted or updated for Macrogenics (MGNX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Macrogenics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Macrogenics was filed on May 20, 2025 so you should expect the next rating to be made available sometime around May 20, 2026.
Is the Analyst Rating Macrogenics (MGNX) correct?
While ratings are subjective and will change, the latest Macrogenics (MGNX) rating was a maintained with a price target of $5.00 to $3.00. The current price Macrogenics (MGNX) is trading at is $1.39, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
